BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21502381)

  • 21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of
    Keat N; Kenny J; Chen K; Onega M; Garman N; Slack RJ; Parker CA; Lumbers RT; Hallett W; Saleem A; Passchier J; Lukey PT
    J Nucl Med Technol; 2018 Jun; 46(2):136-143. PubMed ID: 29438002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Biodistribution and Radiation Dosimetry of
    Barrio MJ; Spick C; Radu CG; Lassmann M; Eberlein U; Allen-Auerbach M; Schiepers C; Slavik R; Czernin J; Herrmann K
    J Nucl Med; 2017 Mar; 58(3):374-378. PubMed ID: 27811125
    [No Abstract]   [Full Text] [Related]  

  • 24. 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.
    Wu Z; Li ZB; Cai W; He L; Chin FT; Li F; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1823-1831. PubMed ID: 17492285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosimetric measurements of (68)Ga-high affinity DOTATATE: twins in spirit - part III.
    Hartmann H; Freudenberg R; Oehme L; Zöphel K; Schottelius M; Wester HJ; Wunderlich G; Kotzerke J; Brogsitter C
    Nuklearmedizin; 2014; 53(5):211-6. PubMed ID: 25029274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution and radiation dosimetry of (68)Ga-PSMA HBED CC-a PSMA specific probe for PET imaging of prostate cancer.
    Pfob CH; Ziegler S; Graner FP; Köhner M; Schachoff S; Blechert B; Wester HJ; Scheidhauer K; Schwaiger M; Maurer T; Eiber M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1962-70. PubMed ID: 27207281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
    Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies.
    Chin FT; Shen B; Liu S; Berganos RA; Chang E; Mittra E; Chen X; Gambhir SS
    Mol Imaging Biol; 2012 Feb; 14(1):88-95. PubMed ID: 21400112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).
    Laymon CM; Narendran R; Mason NS; Carney JP; Lopresti BJ; Mathis CA; Mountz JM; Sashin D; Frankle WG
    Mol Imaging Biol; 2012 Feb; 14(1):115-22. PubMed ID: 21365327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-body biodistribution kinetics, metabolism, and radiation dosimetry estimates of 18F-PEG6-IPQA in nonhuman primates.
    Tian M; Ogawa K; Wendt R; Mukhopadhyay U; Balatoni J; Fukumitsu N; Uthamanthil R; Borne A; Brammer D; Jackson J; Mawlawi O; Yang B; Alauddin MM; Gelovani JG
    J Nucl Med; 2011 Jun; 52(6):934-41. PubMed ID: 21571803
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
    Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET-Based Human Dosimetry of the Dimeric αvβ3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    López-Rodríguez V; Galindo-Sarco C; García-Pérez FO; Ferro-Flores G; Arrieta O; Ávila-Rodríguez MA
    J Nucl Med; 2016 Mar; 57(3):404-9. PubMed ID: 26585063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
    Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
    Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice.
    Lang L; Li W; Guo N; Ma Y; Zhu L; Kiesewetter DO; Shen B; Niu G; Chen X
    Bioconjug Chem; 2011 Dec; 22(12):2415-22. PubMed ID: 22026940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
    Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
    Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
    Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
    J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model.
    Guo N; Lang L; Gao H; Niu G; Kiesewetter DO; Xie Q; Chen X
    Mol Imaging Biol; 2012 Dec; 14(6):743-52. PubMed ID: 22437879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging.
    Maddahi J; Bengel F; Czernin J; Crane P; Dahlbom M; Schelbert H; Sparks R; Phelps M; Lazewatsky J
    J Nucl Cardiol; 2019 Dec; 26(6):2018-2030. PubMed ID: 30488323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PET.
    Laymon CM; Mason NS; Frankle WG; Carney JP; Lopresti BJ; Litschge MY; Mathis CA; Mountz JM; Narendran R
    J Nucl Med; 2009 May; 50(5):814-7. PubMed ID: 19372487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.